Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview.

Giuliano E, Paolino D, Fresta M, Cosco D.

Pharmaceutics. 2018 Sep 12;10(3). pii: E159. doi: 10.3390/pharmaceutics10030159. Review.

2.

Amino-functionalized poloxamer 407 with both mucoadhesive and thermosensitive properties: preparation, characterization and application in a vaginal drug delivery system.

Ci L, Huang Z, Liu Y, Liu Z, Wei G, Lu W.

Acta Pharm Sin B. 2017 Sep;7(5):593-602. doi: 10.1016/j.apsb.2017.03.002. Epub 2017 May 3.

3.

Preparation and irradiation of Pluronic F127-based thermoreversible and mucoadhesive hydrogel for local delivery of naproxen.

Shin BK, Baek EJ, Choi SG, Davaa E, Nho YC, Lim YM, Park JS, Huh KM, Park JS.

Drug Dev Ind Pharm. 2013 Dec;39(12):1874-80. doi: 10.3109/03639045.2012.665925. Epub 2012 Mar 12.

PMID:
22409199
4.

Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl.

Shastri DH, Prajapati ST, Patel LD.

Curr Drug Deliv. 2010 Jul;7(3):238-43.

PMID:
20497100
5.

Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.

Jones DS, Bruschi ML, de Freitas O, Gremião MP, Lara EH, Andrews GP.

Int J Pharm. 2009 May 8;372(1-2):49-58. doi: 10.1016/j.ijpharm.2009.01.006. Epub 2009 Jan 18.

PMID:
19429268
6.

Pluronic/gelatin composites for controlled release of actives.

Tatini D, Tempesti P, Ridi F, Fratini E, Bonini M, Baglioni P.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:400-7. doi: 10.1016/j.colsurfb.2015.08.002. Epub 2015 Aug 5.

PMID:
26277715
7.

Drug-Loaded Biocompatible Nanocarriers Embedded in Poloxamer 407 Hydrogels as Therapeutic Formulations.

Giuliano E, Paolino D, Fresta M, Cosco D.

Medicines (Basel). 2018 Dec 29;6(1). pii: E7. doi: 10.3390/medicines6010007. Review.

8.

Study in vivo intraocular biocompatibility of in situ gelation hydrogels: poly(2-ethyl oxazoline)-block-poly(ε-caprolactone)-block-poly(2-ethyl oxazoline) copolymer, matrigel and pluronic F127.

Hwang YS, Chiang PR, Hong WH, Chiao CC, Chu IM, Hsiue GH, Shen CR.

PLoS One. 2013 Jul 1;8(7):e67495. doi: 10.1371/journal.pone.0067495. Print 2013.

9.

Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base.

Baloglu E, Karavana SY, Senyigit ZA, Guneri T.

Pharm Dev Technol. 2011 Nov-Dec;16(6):627-36. doi: 10.3109/10837450.2010.508074. Epub 2010 Aug 17.

PMID:
20715905
10.

Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids.

Aka-Any-Grah A, Bouchemal K, Koffi A, Agnely F, Zhang M, Djabourov M, Ponchel G.

Eur J Pharm Biopharm. 2010 Oct;76(2):296-303. doi: 10.1016/j.ejpb.2010.07.004. Epub 2010 Jul 23.

PMID:
20656027
11.

Studies on Poloxamer Based Mucoadhesive Insitu Ophthalmic Hydrogel of Moxifloxacin HCL.

Shastri DH, Prajapati ST, Patel LD.

Curr Drug Deliv. 2010 Feb 17. [Epub ahead of print]

PMID:
20158483
12.

Enzyme-mediated cross-linking of Pluronic copolymer micelles for injectable and in situ forming hydrogels.

Lee SH, Lee Y, Lee SW, Ji HY, Lee JH, Lee DS, Park TG.

Acta Biomater. 2011 Apr;7(4):1468-76. doi: 10.1016/j.actbio.2010.11.029. Epub 2010 Nov 25.

PMID:
21111850
13.

Thermogelling properties of purified poloxamer 407.

Fakhari A, Corcoran M, Schwarz A.

Heliyon. 2017 Aug 30;3(8):e00390. doi: 10.1016/j.heliyon.2017.e00390. eCollection 2017 Aug.

14.

Gelation and micellization behaviors of pluronic(®) F127 hydrogel containing poly(isobutylcyanoacrylate) nanoparticles specifically designed for mucosal application.

Pradines B, Djabourov M, Vauthier C, Loiseau PM, Ponchel G, Bouchemal K.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:669-76. doi: 10.1016/j.colsurfb.2015.08.021. Epub 2015 Aug 22.

PMID:
26340355
15.
16.

A review of poloxamer 407 pharmaceutical and pharmacological characteristics.

Dumortier G, Grossiord JL, Agnely F, Chaumeil JC.

Pharm Res. 2006 Dec;23(12):2709-28. Epub 2006 Nov 11. Review.

PMID:
17096184
17.

In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) copolymer.

Gong CY, Shi S, Dong PW, Zheng XL, Fu SZ, Guo G, Yang JL, Wei YQ, Qian ZY.

BMC Biotechnol. 2009 Feb 11;9:8. doi: 10.1186/1472-6750-9-8.

18.

In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery.

He C, Kim SW, Lee DS.

J Control Release. 2008 May 8;127(3):189-207. doi: 10.1016/j.jconrel.2008.01.005. Epub 2008 Jan 26. Review.

PMID:
18321604
19.

Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.

Radivojša M, Grabnar I, Ahlin Grabnar P.

Eur J Pharm Sci. 2013 Sep 27;50(1):93-101. doi: 10.1016/j.ejps.2013.03.002. Epub 2013 Mar 21.

PMID:
23524253
20.

Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide.

Yuan Y, Cui Y, Zhang L, Zhu HP, Guo YS, Zhong B, Hu X, Zhang L, Wang XH, Chen L.

Int J Pharm. 2012 Jul 1;430(1-2):114-9. doi: 10.1016/j.ijpharm.2012.03.054. Epub 2012 Apr 5.

PMID:
22503953

Supplemental Content

Support Center